Table 6. Proportion of isolates with nonsusceptibility to antimicrobial drugs in countries in the ICS reporting an antibiogram*.
| Antimicrobial drug | Age group, y | Alaska |
Northern Canada |
Iceland, % (n/N) | Northern Sweden, % (n/N) | |||
|---|---|---|---|---|---|---|---|---|
| Pre-PCV7, % (n/N) | Post-PCV7, % (n/N) | Pre-PCV7, % (n/N) | Post-PCV7, % (n/N) | |||||
| Cotrimoxazole | <2 | 58 (36/62) | 34 (26/77) | 9 (3/33) | 17 (2/12) | 35 (13/37) | 100 (1/1) | |
| All ages | 31 (70/224) | 21 (96/453) | 9 (14/158) | 9 (7/78) | 18 (43/234) | 12 (3/25) | ||
| Erythromycin | <2 | 42 (26/62) | 13 (10/77) | 0 (0/33) | 8 (1/13) | 26 (10/38) | 0 (0/2) | |
| All ages | 21 (47/223) | 8 (37/452) | 1 (1/157) | 5 (4/79) | 9 (21/235) | 6 (3/53) | ||
| Ceftriaxone† | <2 | 23 (14/62) | 5 (4/77) | 6 (2/33) | 0 (0/12) | 0 (0/10) | NA | |
| All ages | 11 (25/224) | 1 (6/453) | 4 (7/159) | 0 (0/80) | 0 (0/39) | NA | ||
| Penicillin‡ | <2 | 40 (25/62) | 29 (22/77) | 6 (2/33) | 0 (0/13) | 13 (5/38) | 0 (0/1) | |
| All ages | 22 (50/224) | 15 (68/453) | 5 (8/159) | 4 (3/81) | 8 (20/236) | 2 (1/52) | ||
*ICS, International Circumpolar Surveillance; PCV7, 7-valent pneumococcal conjugate vaccine; NA, not available. †Greenland reported nonsusceptibility of 0% (0/38) to ceftriaxone among all ages. ‡Greenland reported nonsusceptibility of 0% (0/41) and Finland reported nonsusceptibility of 6% (236/4,049) to penicillin among all ages. Finland reported nonsusceptibility of 9% (33/367) to penicillin among cases <2 y of age.